Head-To-Head Survey: Trimedyne (OTCMKTS:TMED) vs. Helius Medical Technologies (NASDAQ:HSDT)

Trimedyne (OTCMKTS:TMED) and Helius Medical Technologies (NASDAQ:HSDT) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Trimedyne and Helius Medical Technologies, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trimedyne 0 0 0 0 N/A
Helius Medical Technologies 0 1 1 0 2.50

Helius Medical Technologies has a consensus price target of $20.00, suggesting a potential upside of 177.39%. Given Helius Medical Technologies’ higher probable upside, analysts plainly believe Helius Medical Technologies is more favorable than Trimedyne.

Institutional and Insider Ownership

30.2% of Helius Medical Technologies shares are owned by institutional investors. 11.1% of Trimedyne shares are owned by company insiders. Comparatively, 8.1% of Helius Medical Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Trimedyne and Helius Medical Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Trimedyne N/A N/A N/A
Helius Medical Technologies -3,640.44% -227.11% -166.44%

Earnings and Valuation

This table compares Trimedyne and Helius Medical Technologies’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Trimedyne N/A N/A N/A N/A N/A
Helius Medical Technologies $660,000.00 26.15 -$14.13 million ($8.01) -0.90

Trimedyne has higher earnings, but lower revenue than Helius Medical Technologies.

About Trimedyne

Trimedyne, Inc. manufactures and sells lasers, and disposable and reusable fiber-optic laser devices for use in the medical field. It offers lasers, fibers, needles, and switch tips for use in orthopedics, urology, ear and nose surgery, throat surgery, gynecology, gastrointestinal surgery, general surgery, and other medical specialties. The company also provides 80 watt and 30 watt holmium lasers, and side firing laser needles to treat herniated or ruptured spinal discs. In addition, it engages in the provision of services, and rental of lasers and other medical equipment to hospitals and surgery centers on a fee-per-case basis. The company operates in Asia, Europe, Latin America, the Middle East, Australia, and internationally. It markets its products through commission sales representatives in the United States and independent distributors internationally. Trimedyne, Inc. was founded in 1980 and is based in Irvine, California.

About Helius Medical Technologies

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational Portable Neuromodulation Stimulator (PoNS), that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA.

Receive News & Ratings for Trimedyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trimedyne and related companies with MarketBeat.com's FREE daily email newsletter.